indica (Peskan-Berghofer et al., 2004)
However, its use beyond this approved indication, such as for erectile dysfunction in men, is considered off-label
In that original characterization, ipamorelin raised growth hormone without meaningfully raising cortisol, adrenocorticotropic hormone (ACTH), or prolactin, which separated it from earlier growth hormone-releasing peptides such as GHRP-6 and GHRP-2
If alternative therapy is needed, caution should be exercised when considering other GLP-1 receptor agonists due to potential cross-reactivity
During treatment: Most patients experience minimal discomfort and can resume daily activities afterward
Is this something patients are going to be on forever